Rank | Gene Set | Z-score |
---|---|---|
1 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.20226405 |
2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.89407149 |
3 | oxygen transport (GO:0015671) | 7.31450070 |
4 | heme biosynthetic process (GO:0006783) | 6.92984832 |
5 | gas transport (GO:0015669) | 6.51791570 |
6 | porphyrin-containing compound biosynthetic process (GO:0006779) | 6.15839161 |
7 | * heme metabolic process (GO:0042168) | 5.80898457 |
8 | tetrapyrrole biosynthetic process (GO:0033014) | 5.47567095 |
9 | * porphyrin-containing compound metabolic process (GO:0006778) | 5.18338832 |
10 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.51876403 |
11 | erythrocyte maturation (GO:0043249) | 4.12488884 |
12 | neutrophil activation involved in immune response (GO:0002283) | 3.61511135 |
13 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60477962 |
14 | cellular response to arsenic-containing substance (GO:0071243) | 3.58963734 |
15 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.56935136 |
16 | aldehyde catabolic process (GO:0046185) | 3.56615765 |
17 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.48757373 |
18 | * tetrapyrrole metabolic process (GO:0033013) | 3.42337719 |
19 | glycosphingolipid catabolic process (GO:0046479) | 3.40716509 |
20 | amino sugar catabolic process (GO:0046348) | 3.33428245 |
21 | hemoglobin metabolic process (GO:0020027) | 3.27185629 |
22 | pigment biosynthetic process (GO:0046148) | 3.21991912 |
23 | DNA deamination (GO:0045006) | 3.14482229 |
24 | erythrocyte development (GO:0048821) | 3.14466062 |
25 | ribosomal small subunit assembly (GO:0000028) | 3.12216382 |
26 | reactive oxygen species biosynthetic process (GO:1903409) | 3.10062835 |
27 | glycolipid catabolic process (GO:0019377) | 3.08141611 |
28 | positive regulation of interferon-alpha production (GO:0032727) | 3.06959257 |
29 | pentose-phosphate shunt (GO:0006098) | 3.05584129 |
30 | GDP-mannose metabolic process (GO:0019673) | 3.03580137 |
31 | oligosaccharide catabolic process (GO:0009313) | 3.03562245 |
32 | pentose metabolic process (GO:0019321) | 3.00414870 |
33 | myeloid cell development (GO:0061515) | 2.97638061 |
34 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.96148375 |
35 | regulation of mast cell degranulation (GO:0043304) | 2.95909629 |
36 | negative regulation of interleukin-12 production (GO:0032695) | 2.91672504 |
37 | N-acetylneuraminate metabolic process (GO:0006054) | 2.90335013 |
38 | granulocyte differentiation (GO:0030851) | 2.90153902 |
39 | response to peptidoglycan (GO:0032494) | 2.89447870 |
40 | response to arsenic-containing substance (GO:0046685) | 2.87296148 |
41 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.87059771 |
42 | regulation of interferon-alpha production (GO:0032647) | 2.86747965 |
43 | proteasome assembly (GO:0043248) | 2.86381540 |
44 | * pigment metabolic process (GO:0042440) | 2.86013818 |
45 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.82967056 |
46 | hydrogen peroxide catabolic process (GO:0042744) | 2.81087134 |
47 | immunoglobulin mediated immune response (GO:0016064) | 2.80182917 |
48 | modulation by virus of host process (GO:0019054) | 2.77194062 |
49 | plasma lipoprotein particle assembly (GO:0034377) | 2.75967984 |
50 | modulation by symbiont of host defense response (GO:0052031) | 2.74385915 |
51 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.74385915 |
52 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.74385915 |
53 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.74385915 |
54 | modulation by symbiont of host immune response (GO:0052553) | 2.74385915 |
55 | positive regulation by symbiont of host defense response (GO:0052509) | 2.74385915 |
56 | cysteine metabolic process (GO:0006534) | 2.73632976 |
57 | viral transcription (GO:0019083) | 2.73465200 |
58 | response to interferon-beta (GO:0035456) | 2.71516589 |
59 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71421414 |
60 | natural killer cell mediated immunity (GO:0002228) | 2.71421414 |
61 | hydrogen peroxide metabolic process (GO:0042743) | 2.71070088 |
62 | respiratory burst (GO:0045730) | 2.70610874 |
63 | NADPH regeneration (GO:0006740) | 2.69302310 |
64 | regulation of response to osmotic stress (GO:0047484) | 2.68230319 |
65 | plasma lipoprotein particle clearance (GO:0034381) | 2.67253307 |
66 | modulation by symbiont of host cellular process (GO:0044068) | 2.66296113 |
67 | ceramide catabolic process (GO:0046514) | 2.65732948 |
68 | regulation of superoxide anion generation (GO:0032928) | 2.64154171 |
69 | response to nitrosative stress (GO:0051409) | 2.63971543 |
70 | macrophage activation involved in immune response (GO:0002281) | 2.62853569 |
71 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.62756562 |
72 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.62684335 |
73 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.62684335 |
74 | response to thyroid hormone (GO:0097066) | 2.62164064 |
75 | translational termination (GO:0006415) | 2.61960717 |
76 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.61285539 |
77 | potassium ion export (GO:0071435) | 2.60826734 |
78 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.59026110 |
79 | regulation of cholesterol storage (GO:0010885) | 2.58413879 |
80 | detection of other organism (GO:0098543) | 2.57585336 |
81 | lysine metabolic process (GO:0006553) | 2.57048154 |
82 | lysine catabolic process (GO:0006554) | 2.57048154 |
83 | cellular response to interferon-beta (GO:0035458) | 2.55890093 |
84 | protein autoprocessing (GO:0016540) | 2.55729262 |
85 | response to oxygen radical (GO:0000305) | 2.55607017 |
86 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.55031957 |
87 | one-carbon compound transport (GO:0019755) | 2.54424768 |
88 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.54314785 |
89 | cellular response to oxygen radical (GO:0071450) | 2.54022634 |
90 | removal of superoxide radicals (GO:0019430) | 2.54022634 |
91 | cellular response to superoxide (GO:0071451) | 2.54022634 |
92 | NAD biosynthetic process (GO:0009435) | 2.53638620 |
93 | purine-containing compound salvage (GO:0043101) | 2.53556432 |
94 | detection of bacterium (GO:0016045) | 2.52430060 |
95 | superoxide anion generation (GO:0042554) | 2.52264219 |
96 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.52257612 |
97 | erythrocyte differentiation (GO:0030218) | 2.51164618 |
98 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.49055785 |
99 | positive regulation of megakaryocyte differentiation (GO:0045654) | 2.48326641 |
100 | cellular response to zinc ion (GO:0071294) | 2.47687247 |
101 | phospholipid efflux (GO:0033700) | 2.47622233 |
102 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.47116484 |
103 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.47116484 |
104 | blood coagulation, intrinsic pathway (GO:0007597) | 2.46315480 |
105 | regulation of cholesterol esterification (GO:0010872) | 2.45881962 |
106 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.44722594 |
107 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.44722594 |
108 | granulocyte activation (GO:0036230) | 2.43959885 |
109 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.43782142 |
110 | low-density lipoprotein particle clearance (GO:0034383) | 2.43765467 |
111 | protein carboxylation (GO:0018214) | 2.42550021 |
112 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.42550021 |
113 | neutrophil activation (GO:0042119) | 2.42261784 |
114 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42053458 |
115 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.40470743 |
116 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.39872763 |
117 | protein-lipid complex assembly (GO:0065005) | 2.39551561 |
118 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.39264007 |
119 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.39154058 |
120 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.38916815 |
121 | glucose catabolic process (GO:0006007) | 2.36927531 |
122 | iron ion transport (GO:0006826) | 2.36496775 |
123 | detection of external biotic stimulus (GO:0098581) | 2.36394178 |
124 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.35155848 |
125 | autophagic vacuole fusion (GO:0000046) | 2.33507831 |
126 | pyrimidine-containing compound salvage (GO:0008655) | 2.32792280 |
127 | pyrimidine nucleoside salvage (GO:0043097) | 2.32792280 |
128 | response to lead ion (GO:0010288) | 2.32191539 |
129 | oxaloacetate metabolic process (GO:0006107) | 2.31670326 |
130 | cofactor biosynthetic process (GO:0051188) | 2.31452134 |
131 | regulation of erythrocyte differentiation (GO:0045646) | 2.30514499 |
132 | translational elongation (GO:0006414) | 2.30400411 |
133 | response to superoxide (GO:0000303) | 2.29571562 |
134 | transferrin transport (GO:0033572) | 2.29550136 |
135 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.28816611 |
136 | detection of molecule of bacterial origin (GO:0032490) | 2.28773256 |
137 | B cell mediated immunity (GO:0019724) | 2.28561386 |
138 | regulation of superoxide metabolic process (GO:0090322) | 2.28420328 |
139 | plasma lipoprotein particle organization (GO:0071827) | 2.27669725 |
140 | glucuronate metabolic process (GO:0019585) | 2.27617981 |
141 | uronic acid metabolic process (GO:0006063) | 2.27617981 |
142 | iron ion import (GO:0097286) | 2.27539959 |
143 | heme transport (GO:0015886) | 2.27508506 |
144 | cellular iron ion homeostasis (GO:0006879) | 2.26458957 |
145 | response to methylmercury (GO:0051597) | 2.25609610 |
146 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.25224650 |
147 | eosinophil chemotaxis (GO:0048245) | 2.25221822 |
148 | copper ion transport (GO:0006825) | 2.24965459 |
149 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.24879045 |
150 | regulation of leukocyte degranulation (GO:0043300) | 2.24863448 |
151 | iron ion homeostasis (GO:0055072) | 2.24796902 |
152 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.24779768 |
153 | phagosome maturation (GO:0090382) | 2.24672537 |
154 | proline biosynthetic process (GO:0006561) | 2.22920190 |
155 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.22485735 |
156 | viral protein processing (GO:0019082) | 2.22302501 |
157 | myeloid cell activation involved in immune response (GO:0002275) | 2.22032435 |
158 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.21554395 |
159 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.17014843 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.67006057 |
2 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.11726111 |
3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.77299158 |
4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.68486537 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.43302112 |
6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.10061539 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.60213572 |
8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.53254234 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.40429088 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.34756805 |
11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.34641470 |
12 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.34483829 |
13 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.22335157 |
14 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.18478033 |
15 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.13416727 |
16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.04367015 |
17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.98303637 |
18 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.96024999 |
19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.93329749 |
20 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.91649067 |
21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.89799129 |
22 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.88581419 |
23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.86133327 |
24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.84766720 |
25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.83461140 |
26 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.80875271 |
27 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.80666389 |
28 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.78571355 |
29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.77417514 |
30 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75589704 |
31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.75001338 |
32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.73454130 |
33 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.71973922 |
34 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.71961627 |
35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71812546 |
36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71246153 |
37 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.71120597 |
38 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.70426794 |
39 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.69602481 |
40 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.63463334 |
41 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.63456206 |
42 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62889081 |
43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60681971 |
44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.58282727 |
45 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.57690596 |
46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.56257298 |
47 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55874182 |
48 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54753717 |
49 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.54728364 |
50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.53115367 |
51 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.50984774 |
52 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.50482449 |
53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.46394767 |
54 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.45983296 |
55 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.45589971 |
56 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.45034210 |
57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.44804764 |
58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44695410 |
59 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.43336191 |
60 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43036840 |
61 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41946921 |
62 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.41892872 |
63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.41659811 |
64 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.40751429 |
65 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39646415 |
66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38460627 |
67 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.38377817 |
68 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37745251 |
69 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.35277630 |
70 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33284456 |
71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.32479158 |
72 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31335380 |
73 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30281656 |
74 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.29340348 |
75 | * PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.29145223 |
76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28998581 |
77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.28131333 |
78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28034493 |
79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.27713580 |
80 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.26606400 |
81 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.26588939 |
82 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25860729 |
83 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25322679 |
84 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24069659 |
85 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.23344077 |
86 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23256343 |
87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22646392 |
88 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21988104 |
89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.21507242 |
90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.21130664 |
91 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20364301 |
92 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.20288468 |
93 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.19549266 |
94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18732035 |
95 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17082357 |
96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17006942 |
97 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14336980 |
98 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.14114142 |
99 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.14106660 |
100 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12569887 |
101 | P68_20966046_ChIP-Seq_HELA_Human | 1.11532143 |
102 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.10826362 |
103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09626275 |
104 | MAF_26560356_Chip-Seq_TH2_Human | 1.09388258 |
105 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09261489 |
106 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.07999493 |
107 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07774076 |
108 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07286822 |
109 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07055474 |
110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.06539726 |
111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06418199 |
112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.05737969 |
113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.05341018 |
114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04642807 |
115 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03813021 |
116 | MAF_26560356_Chip-Seq_TH1_Human | 1.03554809 |
117 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01167366 |
118 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.00276908 |
119 | MYC_22102868_ChIP-Seq_BL_Human | 0.99849841 |
120 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95325061 |
121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93708455 |
122 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.93423458 |
123 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.93243988 |
124 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.93105062 |
125 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.92817151 |
126 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92389132 |
127 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90745649 |
128 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.88559740 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003656_abnormal_erythrocyte_physiolo | 6.15136393 |
2 | MP0004147_increased_porphyrin_level | 4.47271337 |
3 | MP0003806_abnormal_nucleotide_metabolis | 3.05524755 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.02405188 |
5 | MP0003186_abnormal_redox_activity | 2.99286578 |
6 | MP0001835_abnormal_antigen_presentation | 2.90786683 |
7 | MP0005451_abnormal_body_composition | 2.82339322 |
8 | MP0003436_decreased_susceptibility_to | 2.64305673 |
9 | MP0005397_hematopoietic_system_phenotyp | 2.54007439 |
10 | MP0001545_abnormal_hematopoietic_system | 2.54007439 |
11 | MP0009840_abnormal_foam_cell | 2.52095488 |
12 | MP0005360_urolithiasis | 2.51175459 |
13 | MP0009785_altered_susceptibility_to | 2.34191767 |
14 | MP0003191_abnormal_cellular_cholesterol | 2.20011331 |
15 | MP0008260_abnormal_autophagy | 2.19768410 |
16 | MP0002148_abnormal_hypersensitivity_rea | 2.17509034 |
17 | MP0005085_abnormal_gallbladder_physiolo | 2.17234694 |
18 | MP0005083_abnormal_biliary_tract | 2.13212668 |
19 | MP0003724_increased_susceptibility_to | 2.10515091 |
20 | MP0006082_CNS_inflammation | 2.09660332 |
21 | MP0005025_abnormal_response_to | 2.00229778 |
22 | MP0009764_decreased_sensitivity_to | 1.97196692 |
23 | MP0002419_abnormal_innate_immunity | 1.92690396 |
24 | MP0000685_abnormal_immune_system | 1.90747139 |
25 | MP0005000_abnormal_immune_tolerance | 1.89502542 |
26 | MP0002132_abnormal_respiratory_system | 1.85080302 |
27 | MP0008875_abnormal_xenobiotic_pharmacok | 1.77459120 |
28 | MP0001853_heart_inflammation | 1.77042044 |
29 | MP0005464_abnormal_platelet_physiology | 1.75454805 |
30 | MP0006054_spinal_hemorrhage | 1.71712481 |
31 | MP0008469_abnormal_protein_level | 1.59324488 |
32 | MP0002452_abnormal_antigen_presenting | 1.59089022 |
33 | MP0005671_abnormal_response_to | 1.58891039 |
34 | MP0003195_calcinosis | 1.58645928 |
35 | MP0005365_abnormal_bile_salt | 1.58467059 |
36 | MP0001800_abnormal_humoral_immune | 1.52482457 |
37 | MP0003303_peritoneal_inflammation | 1.52190447 |
38 | MP0002723_abnormal_immune_serum | 1.50450322 |
39 | MP0005387_immune_system_phenotype | 1.49432270 |
40 | MP0001790_abnormal_immune_system | 1.49432270 |
41 | MP0009333_abnormal_splenocyte_physiolog | 1.49404326 |
42 | MP0002405_respiratory_system_inflammati | 1.47824322 |
43 | MP0005058_abnormal_lysosome_morphology | 1.45320264 |
44 | MP0005636_abnormal_mineral_homeostasis | 1.44672663 |
45 | MP0000609_abnormal_liver_physiology | 1.37635012 |
46 | MP0002398_abnormal_bone_marrow | 1.34421692 |
47 | MP0002138_abnormal_hepatobiliary_system | 1.33277650 |
48 | MP0001845_abnormal_inflammatory_respons | 1.32995978 |
49 | MP0003693_abnormal_embryo_hatching | 1.32570793 |
50 | MP0005319_abnormal_enzyme/_coenzyme | 1.31911688 |
51 | MP0010329_abnormal_lipoprotein_level | 1.30208317 |
52 | MP0001819_abnormal_immune_cell | 1.29936647 |
53 | MP0003111_abnormal_nucleus_morphology | 1.28997353 |
54 | MP0002420_abnormal_adaptive_immunity | 1.28289482 |
55 | MP0000689_abnormal_spleen_morphology | 1.28279503 |
56 | MP0000343_altered_response_to | 1.26470065 |
57 | MP0001764_abnormal_homeostasis | 1.23866767 |
58 | MP0004947_skin_inflammation | 1.21820107 |
59 | MP0000015_abnormal_ear_pigmentation | 1.20200072 |
60 | MP0003453_abnormal_keratinocyte_physiol | 1.20184340 |
61 | MP0002722_abnormal_immune_system | 1.20146863 |
62 | MP0009763_increased_sensitivity_to | 1.19711978 |
63 | MP0001533_abnormal_skeleton_physiology | 1.19368190 |
64 | MP0000490_abnormal_crypts_of | 1.19274082 |
65 | MP0002429_abnormal_blood_cell | 1.18664628 |
66 | MP0003300_gastrointestinal_ulcer | 1.17897783 |
67 | MP0003075_altered_response_to | 1.16629014 |
68 | MP0006036_abnormal_mitochondrial_physio | 1.15919251 |
69 | MP0000858_altered_metastatic_potential | 1.12589610 |
70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09639531 |
71 | MP0000716_abnormal_immune_system | 1.09449969 |
72 | MP0010307_abnormal_tumor_latency | 1.06908402 |
73 | MP0005377_hearing/vestibular/ear_phenot | 1.05423584 |
74 | MP0003878_abnormal_ear_physiology | 1.05423584 |
75 | MP0000598_abnormal_liver_morphology | 1.01394275 |
76 | MP0010155_abnormal_intestine_physiology | 0.97980381 |
77 | MP0002396_abnormal_hematopoietic_system | 0.97278762 |
78 | MP0003077_abnormal_cell_cycle | 0.97191321 |
79 | MP0003252_abnormal_bile_duct | 0.96179033 |
80 | MP0003011_delayed_dark_adaptation | 0.95311000 |
81 | MP0010094_abnormal_chromosome_stability | 0.93823520 |
82 | MP0006035_abnormal_mitochondrial_morpho | 0.93400034 |
83 | MP0005332_abnormal_amino_acid | 0.92548334 |
84 | MP0005166_decreased_susceptibility_to | 0.92002939 |
85 | MP0005164_abnormal_response_to | 0.90983111 |
86 | MP0005075_abnormal_melanosome_morpholog | 0.90274530 |
87 | MP0002006_tumorigenesis | 0.90019790 |
88 | MP0009643_abnormal_urine_homeostasis | 0.89884427 |
89 | MP0001727_abnormal_embryo_implantation | 0.87152629 |
90 | MP0003448_altered_tumor_morphology | 0.86503670 |
91 | MP0004957_abnormal_blastocyst_morpholog | 0.84303246 |
92 | MP0009278_abnormal_bone_marrow | 0.84221266 |
93 | MP0004510_myositis | 0.83827732 |
94 | MP0005310_abnormal_salivary_gland | 0.82822343 |
95 | MP0002332_abnormal_exercise_endurance | 0.80799300 |
96 | MP0008995_early_reproductive_senescence | 0.79082052 |
97 | MP0000371_diluted_coat_color | 0.78870618 |
98 | MP0004782_abnormal_surfactant_physiolog | 0.77266892 |
99 | MP0008057_abnormal_DNA_replication | 0.76615797 |
100 | MP0000747_muscle_weakness | 0.76168800 |
101 | MP0002019_abnormal_tumor_incidence | 0.75594567 |
102 | MP0005376_homeostasis/metabolism_phenot | 0.75472507 |
103 | MP0000604_amyloidosis | 0.75346044 |
104 | MP0009931_abnormal_skin_appearance | 0.74921220 |
105 | MP0003172_abnormal_lysosome_physiology | 0.74156739 |
106 | MP0000358_abnormal_cell_content/ | 0.73007701 |
107 | MP0002254_reproductive_system_inflammat | 0.70261615 |
108 | MP0008004_abnormal_stomach_pH | 0.69460555 |
109 | MP0004185_abnormal_adipocyte_glucose | 0.69348747 |
110 | MP0004808_abnormal_hematopoietic_stem | 0.69293719 |
111 | MP0000313_abnormal_cell_death | 0.69074047 |
112 | MP0008873_increased_physiological_sensi | 0.69012452 |
113 | MP0002118_abnormal_lipid_homeostasis | 0.68991852 |
114 | MP0004019_abnormal_vitamin_homeostasis | 0.68585401 |
115 | MP0002136_abnormal_kidney_physiology | 0.68440525 |
116 | MP0001873_stomach_inflammation | 0.68409666 |
117 | MP0003828_pulmonary_edema | 0.68139245 |
118 | MP0002877_abnormal_melanocyte_morpholog | 0.67426770 |
119 | MP0002166_altered_tumor_susceptibility | 0.65887923 |
120 | MP0009765_abnormal_xenobiotic_induced | 0.65755057 |
121 | MP0005666_abnormal_adipose_tissue | 0.65344261 |
122 | MP0001666_abnormal_nutrient_absorption | 0.65106653 |
123 | MP0003879_abnormal_hair_cell | 0.65096175 |
124 | MP0008874_decreased_physiological_sensi | 0.63107753 |
125 | MP0003786_premature_aging | 0.63079852 |
126 | MP0001542_abnormal_bone_strength | 0.62922403 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 9.20173728 |
2 | Poikilocytosis (HP:0004447) | 5.86029301 |
3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.52559106 |
4 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.52559106 |
5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.52559106 |
6 | Reticulocytosis (HP:0001923) | 4.99366482 |
7 | Abnormal number of erythroid precursors (HP:0012131) | 4.81816546 |
8 | Acanthocytosis (HP:0001927) | 4.74919525 |
9 | Abnormal hemoglobin (HP:0011902) | 4.73854619 |
10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.56718427 |
11 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.15457246 |
12 | Recurrent abscess formation (HP:0002722) | 4.02992841 |
13 | Abnormality of reticulocytes (HP:0004312) | 3.94136685 |
14 | Hyperbilirubinemia (HP:0002904) | 3.93805310 |
15 | Increased serum ferritin (HP:0003281) | 3.89865615 |
16 | Petechiae (HP:0000967) | 3.81428110 |
17 | Recurrent bacterial skin infections (HP:0005406) | 3.78367818 |
18 | Eczematoid dermatitis (HP:0000976) | 3.68832115 |
19 | Autoimmune thrombocytopenia (HP:0001973) | 3.67217453 |
20 | Abnormality of iron homeostasis (HP:0011031) | 3.58505596 |
21 | Nausea (HP:0002018) | 3.55258914 |
22 | Systemic lupus erythematosus (HP:0002725) | 3.53651851 |
23 | Paralysis (HP:0003470) | 3.36164498 |
24 | Cholelithiasis (HP:0001081) | 3.33928310 |
25 | Abnormality of transition element cation homeostasis (HP:0011030) | 3.23816462 |
26 | Hypochromic microcytic anemia (HP:0004840) | 3.23461029 |
27 | Cutaneous photosensitivity (HP:0000992) | 3.06934011 |
28 | Polycythemia (HP:0001901) | 3.06514788 |
29 | Dysostosis multiplex (HP:0000943) | 3.05486441 |
30 | Abnormal gallbladder morphology (HP:0012437) | 3.04585175 |
31 | Hypertensive crisis (HP:0100735) | 2.99175117 |
32 | Diaphragmatic weakness (HP:0009113) | 2.96738546 |
33 | Urticaria (HP:0001025) | 2.96106410 |
34 | Pustule (HP:0200039) | 2.87825037 |
35 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.87374725 |
36 | Joint hemorrhage (HP:0005261) | 2.84892543 |
37 | Microcytic anemia (HP:0001935) | 2.80107801 |
38 | Prolonged partial thromboplastin time (HP:0003645) | 2.76287117 |
39 | Hypochromic anemia (HP:0001931) | 2.75551761 |
40 | Abnormality of macrophages (HP:0004311) | 2.73246436 |
41 | Pallor (HP:0000980) | 2.72460202 |
42 | Chronic obstructive pulmonary disease (HP:0006510) | 2.71269438 |
43 | Prolonged bleeding time (HP:0003010) | 2.69686298 |
44 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.66356785 |
45 | Hepatocellular carcinoma (HP:0001402) | 2.65068753 |
46 | Axonal loss (HP:0003447) | 2.64663636 |
47 | Xanthomatosis (HP:0000991) | 2.64290254 |
48 | Mediastinal lymphadenopathy (HP:0100721) | 2.60319106 |
49 | Epistaxis (HP:0000421) | 2.52857724 |
50 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.49727479 |
51 | Loss of speech (HP:0002371) | 2.49533128 |
52 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.43120752 |
53 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.43120752 |
54 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.43120752 |
55 | Complement deficiency (HP:0004431) | 2.42146984 |
56 | Purpura (HP:0000979) | 2.38822106 |
57 | Recurrent skin infections (HP:0001581) | 2.37905326 |
58 | Abnormality of complement system (HP:0005339) | 2.37531571 |
59 | Vacuolated lymphocytes (HP:0001922) | 2.34814175 |
60 | Deep venous thrombosis (HP:0002625) | 2.31671851 |
61 | Glomerulonephritis (HP:0000099) | 2.30731619 |
62 | Poor head control (HP:0002421) | 2.29804882 |
63 | Intrahepatic cholestasis (HP:0001406) | 2.24500035 |
64 | Disinhibition (HP:0000734) | 2.24239323 |
65 | Hypobetalipoproteinemia (HP:0003563) | 2.23224882 |
66 | Cholecystitis (HP:0001082) | 2.21650702 |
67 | Abnormal gallbladder physiology (HP:0012438) | 2.21650702 |
68 | Macrocytic anemia (HP:0001972) | 2.21597050 |
69 | Progressive neurologic deterioration (HP:0002344) | 2.19040312 |
70 | Abnormality of the gallbladder (HP:0005264) | 2.17653604 |
71 | Mucopolysacchariduria (HP:0008155) | 2.16601167 |
72 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16601167 |
73 | Pathologic fracture (HP:0002756) | 2.16362830 |
74 | Ileus (HP:0002595) | 2.14622518 |
75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.14273846 |
76 | Tetraparesis (HP:0002273) | 2.09937322 |
77 | Albinism (HP:0001022) | 2.09889058 |
78 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.08944152 |
79 | Gingival bleeding (HP:0000225) | 2.07070210 |
80 | Reticulocytopenia (HP:0001896) | 2.07061491 |
81 | Birth length less than 3rd percentile (HP:0003561) | 2.05934522 |
82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.05030736 |
83 | Exertional dyspnea (HP:0002875) | 2.04972492 |
84 | Myocardial infarction (HP:0001658) | 2.03128358 |
85 | Gingivitis (HP:0000230) | 2.00209336 |
86 | Cerebral palsy (HP:0100021) | 1.98681861 |
87 | Nonimmune hydrops fetalis (HP:0001790) | 1.98000387 |
88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.96531999 |
89 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.96531999 |
90 | Hepatosplenomegaly (HP:0001433) | 1.96152436 |
91 | Basal ganglia calcification (HP:0002135) | 1.95005152 |
92 | Increased cerebral lipofuscin (HP:0011813) | 1.94055506 |
93 | Hypercholesterolemia (HP:0003124) | 1.93749711 |
94 | Impaired platelet aggregation (HP:0003540) | 1.92658445 |
95 | Abnormal platelet function (HP:0011869) | 1.92658445 |
96 | Hyperthyroidism (HP:0000836) | 1.91614790 |
97 | Abnormality of the common coagulation pathway (HP:0010990) | 1.91515704 |
98 | Cardiomegaly (HP:0001640) | 1.89913786 |
99 | Short middle phalanx of the 5th finger (HP:0004220) | 1.88749057 |
100 | Prostate neoplasm (HP:0100787) | 1.88312253 |
101 | Vertebral compression fractures (HP:0002953) | 1.87082354 |
102 | Increased IgM level (HP:0003496) | 1.86594165 |
103 | Cellulitis (HP:0100658) | 1.86105567 |
104 | Multiple enchondromatosis (HP:0005701) | 1.85880427 |
105 | Increased muscle lipid content (HP:0009058) | 1.84892038 |
106 | Anorexia (HP:0002039) | 1.84665895 |
107 | Vasculitis (HP:0002633) | 1.83763549 |
108 | Splenomegaly (HP:0001744) | 1.83058650 |
109 | Hyperlipoproteinemia (HP:0010980) | 1.81943524 |
110 | Hyperammonemia (HP:0001987) | 1.81368569 |
111 | Recurrent viral infections (HP:0004429) | 1.80653231 |
112 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80580499 |
113 | Nuclear cataract (HP:0100018) | 1.80315674 |
114 | Ragged-red muscle fibers (HP:0003200) | 1.79703635 |
115 | Osteomalacia (HP:0002749) | 1.79121282 |
116 | Prolonged neonatal jaundice (HP:0006579) | 1.79062416 |
117 | Mutism (HP:0002300) | 1.78325481 |
118 | Recurrent fungal infections (HP:0002841) | 1.78036305 |
119 | Lower limb hyperreflexia (HP:0002395) | 1.77623966 |
120 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77084051 |
121 | Toxemia of pregnancy (HP:0100603) | 1.75405884 |
122 | Acute encephalopathy (HP:0006846) | 1.75293891 |
123 | Hypertriglyceridemia (HP:0002155) | 1.74442561 |
124 | Myositis (HP:0100614) | 1.74377239 |
125 | Esophageal neoplasm (HP:0100751) | 1.73500478 |
126 | Neoplasm of head and neck (HP:0012288) | 1.73500478 |
127 | Reduced antithrombin III activity (HP:0001976) | 1.73439260 |
128 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72489159 |
129 | Hepatic necrosis (HP:0002605) | 1.70606343 |
130 | Obstructive lung disease (HP:0006536) | 1.70519744 |
131 | Slow saccadic eye movements (HP:0000514) | 1.70287667 |
132 | Upper motor neuron abnormality (HP:0002127) | 1.69909998 |
133 | Spontaneous hematomas (HP:0007420) | 1.69381701 |
134 | Gastrointestinal infarctions (HP:0005244) | 1.68614203 |
135 | Hepatocellular necrosis (HP:0001404) | 1.68167838 |
136 | Seborrheic dermatitis (HP:0001051) | 1.67383837 |
137 | Stomatitis (HP:0010280) | 1.66874792 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PBK | 4.60146034 |
2 | NME2 | 4.39198051 |
3 | EIF2AK1 | 3.90804397 |
4 | PIM2 | 2.96759429 |
5 | PRPF4B | 2.69101258 |
6 | BLK | 2.59207862 |
7 | TBK1 | 2.56889050 |
8 | MAP3K14 | 2.48736688 |
9 | TYK2 | 2.44413264 |
10 | TLK1 | 2.27930830 |
11 | IRAK3 | 2.14751371 |
12 | IKBKB | 2.02108354 |
13 | STK4 | 2.01580920 |
14 | TESK2 | 1.98062432 |
15 | ERN1 | 1.93047674 |
16 | ABL2 | 1.89454543 |
17 | MAP3K11 | 1.87335229 |
18 | MAP4K1 | 1.83781968 |
19 | RIPK4 | 1.80956976 |
20 | MST4 | 1.77014051 |
21 | IKBKE | 1.74453057 |
22 | PIM1 | 1.62966504 |
23 | BUB1 | 1.60330072 |
24 | RPS6KA4 | 1.59529543 |
25 | IRAK4 | 1.57277437 |
26 | SCYL2 | 1.52997708 |
27 | MAP3K10 | 1.49649625 |
28 | TRIB3 | 1.46839005 |
29 | STK10 | 1.42971110 |
30 | MAP3K1 | 1.38572762 |
31 | TESK1 | 1.33617303 |
32 | NEK9 | 1.33518821 |
33 | KDR | 1.28004197 |
34 | JAK3 | 1.25195587 |
35 | VRK1 | 1.19812058 |
36 | MAP2K3 | 1.18485512 |
37 | BCKDK | 1.17962120 |
38 | JAK2 | 1.16596176 |
39 | MST1R | 1.15493608 |
40 | SYK | 1.15401903 |
41 | LYN | 1.11617713 |
42 | KIT | 1.08368460 |
43 | SMG1 | 1.07923156 |
44 | ZAK | 1.03844827 |
45 | CDC7 | 1.02423191 |
46 | NEK2 | 1.00561510 |
47 | BMPR2 | 0.99578493 |
48 | VRK2 | 0.97566450 |
49 | WEE1 | 0.95849356 |
50 | SIK1 | 0.92016210 |
51 | DYRK3 | 0.91826818 |
52 | MAP3K3 | 0.91131684 |
53 | ACVR1B | 0.91111664 |
54 | KSR2 | 0.89962653 |
55 | CHUK | 0.89882094 |
56 | RAF1 | 0.89136549 |
57 | ZAP70 | 0.88248875 |
58 | FGR | 0.88206014 |
59 | BMX | 0.88178807 |
60 | EIF2AK2 | 0.88046797 |
61 | LRRK2 | 0.87598530 |
62 | MAP3K2 | 0.85971563 |
63 | MAPK11 | 0.85968394 |
64 | TGFBR2 | 0.85693737 |
65 | TAOK3 | 0.85669486 |
66 | MAP3K12 | 0.84316698 |
67 | TNK2 | 0.80256786 |
68 | BTK | 0.77820368 |
69 | MAP3K8 | 0.77678166 |
70 | PAK4 | 0.76700577 |
71 | CDK4 | 0.76300984 |
72 | TRPM7 | 0.74540237 |
73 | JAK1 | 0.72239304 |
74 | MATK | 0.71997848 |
75 | BRSK2 | 0.71843712 |
76 | BRSK1 | 0.71105332 |
77 | STK16 | 0.70849059 |
78 | CDK6 | 0.69967135 |
79 | TAOK2 | 0.69130192 |
80 | TXK | 0.68685760 |
81 | NME1 | 0.67624092 |
82 | AURKA | 0.65829323 |
83 | FLT3 | 0.65351247 |
84 | ARAF | 0.64641564 |
85 | CSF1R | 0.63406699 |
86 | AURKB | 0.63017000 |
87 | MAP3K5 | 0.62689874 |
88 | RPS6KA5 | 0.61988474 |
89 | PDK2 | 0.61552006 |
90 | GRK6 | 0.60540014 |
91 | GRK7 | 0.60198634 |
92 | IRAK2 | 0.58625637 |
93 | PRKCD | 0.56307649 |
94 | CCNB1 | 0.53509802 |
95 | BRAF | 0.53339601 |
96 | ILK | 0.52481637 |
97 | PDPK1 | 0.51945855 |
98 | RPS6KC1 | 0.51569229 |
99 | RPS6KL1 | 0.51569229 |
100 | ICK | 0.51419083 |
101 | HIPK2 | 0.51130454 |
102 | TEC | 0.50899171 |
103 | MAPKAPK2 | 0.50439687 |
104 | ATR | 0.49458910 |
105 | MAP2K6 | 0.48801979 |
106 | PLK1 | 0.47797565 |
107 | CSNK2A1 | 0.47777289 |
108 | EIF2AK3 | 0.47740285 |
109 | CAMK1D | 0.46324396 |
110 | CSK | 0.45839556 |
111 | LCK | 0.45491353 |
112 | DAPK3 | 0.44681883 |
113 | MAPKAPK3 | 0.44675700 |
114 | PAK1 | 0.44197143 |
115 | MAP3K6 | 0.42334647 |
116 | CLK1 | 0.41272525 |
117 | RPS6KA6 | 0.41219455 |
118 | MARK3 | 0.40762149 |
119 | PTK6 | 0.40383343 |
120 | FES | 0.40234169 |
121 | CDK7 | 0.39566143 |
122 | DYRK1B | 0.38409717 |
123 | TAOK1 | 0.38264285 |
124 | MAP2K1 | 0.37042620 |
125 | MAP2K2 | 0.36865113 |
126 | SIK3 | 0.35664939 |
127 | MAPK12 | 0.35141522 |
128 | RPS6KB2 | 0.34822508 |
129 | EPHA2 | 0.34568787 |
130 | YES1 | 0.34266412 |
131 | ABL1 | 0.33680656 |
132 | HCK | 0.33570252 |
133 | IRAK1 | 0.32631967 |
134 | DAPK2 | 0.31380701 |
135 | EGFR | 0.31310393 |
136 | PRKG2 | 0.30967350 |
137 | PIK3CG | 0.30559959 |
138 | CSNK2A2 | 0.30207402 |
139 | PRKAA2 | 0.29604207 |
140 | KSR1 | 0.28657200 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 4.22810700 |
2 | Ribosome_Homo sapiens_hsa03010 | 2.56749341 |
3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.46574475 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.39979928 |
5 | Proteasome_Homo sapiens_hsa03050 | 2.20420940 |
6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.13077363 |
7 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.09567151 |
8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09201176 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.06939658 |
10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.04848107 |
11 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.96240536 |
12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84785840 |
13 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.80672317 |
14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.79868951 |
15 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.70245926 |
16 | Legionellosis_Homo sapiens_hsa05134 | 1.66821082 |
17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66523945 |
18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.65058182 |
19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.57112969 |
20 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.56906755 |
21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56099555 |
22 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51555258 |
23 | Malaria_Homo sapiens_hsa05144 | 1.43989780 |
24 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.43919393 |
25 | Galactose metabolism_Homo sapiens_hsa00052 | 1.37619064 |
26 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.36465960 |
27 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.35054720 |
28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.33720336 |
29 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.32494326 |
30 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.31508884 |
31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.29952150 |
32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28429629 |
33 | Mismatch repair_Homo sapiens_hsa03430 | 1.28007591 |
34 | Peroxisome_Homo sapiens_hsa04146 | 1.27770377 |
35 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.26022481 |
36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.21084600 |
37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.18747318 |
38 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.17379766 |
39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16135674 |
40 | Pertussis_Homo sapiens_hsa05133 | 1.16004633 |
41 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.14771154 |
42 | Base excision repair_Homo sapiens_hsa03410 | 1.13573460 |
43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12822439 |
44 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.12190892 |
45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.11595400 |
46 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09779934 |
47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09494866 |
48 | Asthma_Homo sapiens_hsa05310 | 1.07953336 |
49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07796203 |
50 | Allograft rejection_Homo sapiens_hsa05330 | 1.04522108 |
51 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.04390114 |
52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04349503 |
53 | Measles_Homo sapiens_hsa05162 | 1.02368557 |
54 | ABC transporters_Homo sapiens_hsa02010 | 1.02052691 |
55 | Tuberculosis_Homo sapiens_hsa05152 | 1.01791246 |
56 | Bladder cancer_Homo sapiens_hsa05219 | 1.00971159 |
57 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.00922340 |
58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.97931267 |
59 | Homologous recombination_Homo sapiens_hsa03440 | 0.97516823 |
60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.94682133 |
61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.93827626 |
62 | Prion diseases_Homo sapiens_hsa05020 | 0.93666366 |
63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93324054 |
64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93080009 |
65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.92982496 |
66 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.92555720 |
67 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.91852189 |
68 | Apoptosis_Homo sapiens_hsa04210 | 0.91468138 |
69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88144718 |
70 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88075528 |
71 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85750880 |
72 | Influenza A_Homo sapiens_hsa05164 | 0.84843589 |
73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.84356925 |
74 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.82347269 |
75 | Lysosome_Homo sapiens_hsa04142 | 0.82124916 |
76 | RNA polymerase_Homo sapiens_hsa03020 | 0.81618835 |
77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81574414 |
78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81399762 |
79 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.79879486 |
80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77702872 |
81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76303656 |
82 | Alzheimers disease_Homo sapiens_hsa05010 | 0.75919812 |
83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75528470 |
84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.75134209 |
85 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74705811 |
86 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.73918939 |
87 | Phagosome_Homo sapiens_hsa04145 | 0.71263174 |
88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68822956 |
89 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.68653090 |
90 | Hepatitis C_Homo sapiens_hsa05160 | 0.67954347 |
91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.67581441 |
92 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67483159 |
93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.66548737 |
94 | Shigellosis_Homo sapiens_hsa05131 | 0.66188714 |
95 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64305599 |
96 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63621875 |
97 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.58789812 |
98 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58579520 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58221688 |
100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.58110214 |
101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57558251 |
102 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.56936415 |
103 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55577492 |
104 | Spliceosome_Homo sapiens_hsa03040 | 0.54386629 |
105 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54106014 |
106 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.54090473 |
107 | Hepatitis B_Homo sapiens_hsa05161 | 0.54022063 |
108 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53696275 |
109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.53663118 |
110 | Mineral absorption_Homo sapiens_hsa04978 | 0.50298354 |
111 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50074313 |
112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49966209 |
113 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49335443 |
114 | Salmonella infection_Homo sapiens_hsa05132 | 0.48724811 |
115 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48674567 |
116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48021918 |
117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47919490 |
118 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.46795888 |
119 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.46777139 |
120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46339015 |
121 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.45709323 |
122 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45646770 |
123 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45454211 |
124 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44984535 |
125 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.43419824 |
126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43389345 |
127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42702936 |
128 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.42365424 |
129 | Cell cycle_Homo sapiens_hsa04110 | 0.42242714 |
130 | Other glycan degradation_Homo sapiens_hsa00511 | 0.42082654 |
131 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.41943379 |
132 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40309698 |